Product NDC: | 0143-9674 |
Proprietary Name: | Argatroban |
Non Proprietary Name: | Argatroban |
Active Ingredient(s): | 250 mg/2.5mL & nbsp; Argatroban |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0143-9674 |
Labeler Name: | West-ward Pharmaceutical Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA203049 |
Marketing Category: | NDA |
Start Marketing Date: | 20120105 |
Package NDC: | 0143-9674-01 |
Package Description: | 2.5 mL in 1 VIAL (0143-9674-01) |
NDC Code | 0143-9674-01 |
Proprietary Name | Argatroban |
Package Description | 2.5 mL in 1 VIAL (0143-9674-01) |
Product NDC | 0143-9674 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Argatroban |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120105 |
Marketing Category Name | NDA |
Labeler Name | West-ward Pharmaceutical Corp |
Substance Name | ARGATROBAN |
Strength Number | 250 |
Strength Unit | mg/2.5mL |
Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |